Company Announcements

In a January SEC filing, Thermo Fisher Scientific announced the transfer of its plastics for cell culture and vaccines/biologics; sample preparation and analysis; and production chemicals product lines from its Laboratory Products and Services segment (LPS) to its Life Sciences Solutions segment (LSS). The biochemical product line was transferred from LSS to LPS.

For the fiscal third quarter ending December 31, 2016, sales for Hitachi High-Technologies’ Science and Medical Systems improved 0.7% to ¥42.2 billion ($385.5 million) to account for 27% of company revenues (see IBO 1/31/17). Excluding currency, sales grew roughly 9%, driven by acquisitions and strong demand for clinical analyzers in China. Scientific Instruments sales grew in the low single digits organically, while Electron Microscopes sales contracted in the upper single digits due to weakness in Europe.

Fourth quarter 2016 sales for Sartorius’ Lab Products & Services Division (LPS) grew 9.2%, 7% organically, to €86.9 million ($93.4 million) (see IBO 2/28/17). For the year, LPS sales advanced 6.5%, 5% organically, to €325.3 million ($361.4 million) to account for 25% of revenues. Growth was driven by strong demand for lab filters and microbiological test consumables. Currency-neutral LPS sales in the Americas, EMEA and Asia Pacific expanded 17.3%, 5.9% and 4.7%, to account for 22%, 50% and 28% of LPS revenues, respectively. LPS orders climbed 9.9% excluding currency. The company projected 2017 LPS sales to grow 3%–7% organically.

In March, Antec Leyden, a provider of electrochemical detectors for LC and MS, announced a name change to Antec Scientific.

Judges Scientific’s 2016 revenues grew 2.0% to £57.3 million ($77.4 million), including 2% organic growth (see IBO 3/31/17). Organically, orders rose 2.9%. Materials Sciences revenues were flat to make up 49% of revenues. Vacuum revenue grew 4.5%. Adjusted operating profit declined 2.4% to £28.2 million ($38.1 million).

Halma announced in April that Finance Director Kevin Thompson will retire next year.

In April, Xylem announced that beginning in the second quarter it will combine its Analytics, Sensus and Visenti businesses, and report the results as such.

Luminex announced in April that Jay B. Johnston will retire from the Board in May.

Danaher announced in April that its Pall Water division will now operate in affiliation with the companies that form Danaher’s Water Quality Platform.

Hach, a Danaher company, announced in April a collaboration with Royal HaskoningDHV, under which its analytical instrumentation is certified to test the quality of water treated with Royal HaskoningDHV’s Nereda technology. The companies will also collaborate.

In April, BD named Tom Polen as president. He currently serves as executive vice president and president of BD Medical.

GE Healthcare reported in its first quarter conference call that Life Sciences orders grew 15%, with Bioprocess orders up 15%, driven by an order for the Kubio flexible facility product.